Kuros Biosciences AG (ETR:YTSN)

Kuros Biosciences AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,155	859	138	54	61	61
Market Cap Growth	977.94%	523.03%	153.55%	-10.72%	-0.52%	20.93%
Enterprise Value	1,138	846	123	35	37	50
PS Ratio	14.34	10.66	3.82	2.99	4.57	16.40
PB Ratio	18.45	13.71	2.26	0.78	0.82	0.78
P/TBV Ratio	44.55	33.12	8.15	2.67	3.01	2.45
P/FCF Ratio	529.90	393.96	-	-	-	-
P/OCF Ratio	345.11	256.57	-	-	-	-
EV/Sales Ratio	14.10	10.50	3.41	1.90	2.77	13.27
EV/EBITDA Ratio	-	385.86	-	-	-	-
EV/EBIT Ratio	-	7414.24	-	-	-	-
EV/FCF Ratio	521.94	387.93	-	-	-	-
Debt / Equity Ratio	0.03	0.03	0.04	0.03	0.03	0.03
Debt / EBITDA Ratio	0.66	0.66	-	-	-	-
Debt / FCF Ratio	0.88	0.88	-	-	-	-
Asset Turnover	0.97	0.97	0.44	0.21	0.15	0.04
Inventory Turnover	1.18	1.18	1.27	1.47	2.33	1.96
Quick Ratio	1.64	1.64	2.22	2.20	2.72	7.69
Current Ratio	2.14	2.14	2.77	2.49	2.91	8.76
Return on Equity (ROE)	-6.44%	-6.44%	-16.18%	-20.02%	-9.33%	-14.18%
Return on Assets (ROA)	0.09%	0.09%	-4.12%	-7.06%	-5.90%	-8.09%
Return on Capital (ROIC)	0.11%	0.11%	-4.90%	-8.21%	-6.59%	-8.81%
Return on Capital Employed (ROCE)	0.20%	0.20%	-	-	-	-
Earnings Yield	-0.40%	-0.53%	-10.70%	-27.17%	-11.95%	-17.39%
FCF Yield	0.19%	0.25%	-7.14%	-14.41%	-9.13%	-14.04%
Buyback Yield / Dilution	-3.76%	-1.69%	-7.91%	-3.37%	-34.86%	-53.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.